Skip to content
RL

Rekvina Labs

526075 BSE
Price unavailable

Rekvina Labs (VINRKLB) share price was ₹57.94 at the 28 Oct 2026 close; market capitalisation ₹64.38 Cr; sector Healthcare. In the Jun 2026 quarter, revenue was ₹0.67 Cr, against under ₹0.01 Cr a year earlier and net profit was −₹0.12 Cr, against −₹0.04 Cr a year earlier (compared with Jun 2025). Promoters held 77.00% of Rekvina Labs in Sep 2026, up 35.70 percentage points from Jun 2026.

Close 28 Oct 2026 ₹57.94 +50.86 +718.36% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹64.38 Cr
EBITDA
−₹30.00 L
Return on Equity
20.74%
Debt to Equity
0
Book Value
₹3.47
EPS (TTM)
−₹0.27
52W High
₹65.07
52W Low
₹6.75

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,765.8035.034,23,675 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.0072.351,75,312 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.00108.051,18,166 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.3026.291,17,835 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.6034.671,11,730 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,364.8032.701,10,257 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Rekvina Labs (this company)
——64 Cr16.700.00%20.74%20.74%2 Cr-0 Cr
Median 8 companies₹1,765.8035.031,18,001 Cr7.310.47%14.56%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Promoter holding has increased by 35.7% over last quarter.

Weaknesses

2
  • Company has low interest coverage ratio.
  • Company has high debtors of 172 days.

Technical Indicators

Oscillators

Bullish

Bearish
1
Neutral
5
Bullish
3

Overall

Bullish

Bearish
3
Neutral
5
Bullish
11

Moving Averages

Bullish

Bearish
2
Neutral
0
Bullish
8

Growth Rate

Revenue Growth
—

Net Income Growth
200% level than 5Y

change over 1 year

Cash Flow Change
-211%

change over 1 year

EBITDA Margin Change
—

Operating margin -17.91% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0.2
0.35
0.72
0.67
Expenses
0
0.01
0
0
0
0.07
0.02
0.04
0.04
0.23
0.47
0.78
0.79
Operating Profit
0
-0.01
0
0
0
-0.07
-0.02
-0.04
-0.04
-0.03
-0.12
-0.06
-0.12
OPM %
—
—
—
—
—
—
—
—
—
-15%
-34.29%
-8.33%
-17.91%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
-0.01
0
0
0
-0.07
-0.02
-0.04
-0.04
-0.03
-0.12
-0.06
-0.12
Tax %
—
0%
—
—
—
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
0
-0.01
0
0
0
-0.07
-0.02
-0.04
-0.04
-0.03
-0.12
-0.06
-0.12
EPS (₹)
0
-0.01
0
0
0
-0.06
-0.02
-0.03
-0.03
-0.02
-0.1
-0.05
-0.1
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0.08
0.03
0.06
0
0
0
0
-0.04
0
0
0
1.27
1.94
Expenses
0.05
0.03
0.12
0.05
0.1
0.15
0.06
0.04
0
0.02
0.14
1.52
2.27
Operating Profit
0.03
0
-0.06
-0.05
-0.1
-0.15
-0.06
-0.08
0
-0.02
-0.14
-0.25
-0.33
OPM %
37.5%
0%
-100%
—
—
—
—
—
—
—
—
-19.69%
-17.01%
Other Income
0
0
0
0.03
0.02
0.15
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.03
0
-0.06
-0.02
-0.08
0
-0.06
-0.08
0
-0.02
-0.14
-0.25
-0.33
Tax %
33.33%
—
0%
0%
0%
—
0%
0%
—
0%
0%
0%
—
Net Profit
0.02
0
-0.06
-0.02
-0.08
0
-0.06
-0.08
0
-0.02
-0.14
-0.25
-0.33
EPS (₹)
0.02
0
-0.05
-0.02
-0.07
0
-0.05
-0.07
0
-0.02
-0.12
-0.21
-0.27
Div. Payout %
0%
—
0%
0%
0%
—
0%
0%
—
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.01
3.01
3.01
3.01
3.01
3.01
3.01
3.01
3.01
3.01
3.01
3.01
Reserves
-2.33
-2.45
-2.51
-2.53
-2.61
-2.86
-2.92
-3
-3
-3.21
-3.35
-4.24
Borrowings
0
0.01
0.01
0.17
0.21
0
0
0
0.08
0.04
0.25
1.47
Other Liabilities
0.09
0.09
0.13
0.14
0.19
0.13
0.15
0.18
0.11
0.17
0.12
0.94
Total Liabilities
0.77
0.66
0.64
0.79
0.8
0.28
0.24
0.19
0.2
0.01
0.03
1.18
Fixed Assets
0.27
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0
0
0
Other Assets
0.45
0.46
0.44
0.59
0.6
0.08
0.04
-0.01
0
0.01
0.03
1.18
Total Assets
0.77
0.66
0.64
0.79
0.8
0.28
0.24
0.19
0.2
0.01
0.03
1.18
Figures in ₹ Crores

Cash Flow

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.01
-0.02
-0.04
0.01
-0.02
-0.01
-0.01
-0.04
0.01
-0.01
-0.19
-0.59
Investing
0.01
0.02
0.07
-0.07
0
0
0
0.04
0
0
0
0
Financing
0
0.01
0
0.16
0.04
0
0
0
0
0.01
0.21
0.58
Net Cash Flow
0
0
0.03
0.1
0.01
-0.01
-0.01
0
0.01
0
0.02
-0.01
Free Cash Flow
-0.01
-0.02
-0.04
0.01
-0.02
-0.01
-0.01
-0.04
0.01
-0.01
-0.19
-0.59
CFO/OP
-33
—
67
-20
20
7
17
50
—
50
136
236
Figures in ₹ Crores

Ratios

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
1,004
3,042
1,703
—
—
—
—
—
—
—
—
172
Inventory Days
—
—
—
—
—
—
—
—
—
—
—
0
Cash Conversion Cycle
1,004
3,042
1,703
—
—
—
—
—
—
—
—
172
Working Capital Days
1,460
4,015
1,460
—
—
—
—
—
—
—
—
-359
ROCE %
4.51%
0%
-11.11%
-3.45%
-12.7%
—
-50%
-160%
0%
—
—
-333.33%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Rekvina Labs insights

54 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

Promot.77.00%Others2.97%Public20.03%As ofSep 2026

Documents

1
Concall - Feb 2026 Feb 2026
2
Concall - Nov 2025 Nov 2025
3
Concall - Aug 2025 Aug 2025
4
Concall - May 2025 May 2025
5
Concall - Feb 2025 Feb 2025

Frequently Asked Questions about Rekvina Labs

What does Rekvina Labs Ltd do?
[1]Rekvina Laboratories Limited is engaged in the manufacturing and marketing of pharmaceutical formulations.[2]
Where is Rekvina Labs Ltd (VINRKLB) listed?
Rekvina Labs Ltd trades under code 526075 on the BSE.
Which sector does Rekvina Labs Ltd belong to?
Rekvina Labs Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Rekvina Labs Ltd?
Rekvina Labs Ltd has a market capitalisation of ₹64.38 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Rekvina Labs Ltd?
Over the last 52 weeks Rekvina Labs Ltd has traded between ₹6.75 and ₹65.07 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Rekvina Labs Ltd?
Rekvina Labs Ltd reported a return on equity of 20.74%. Its debt-to-equity ratio is 0.00.

Company Information

[1]Rekvina Laboratories Limited is engaged in the manufacturing and marketing of pharmaceutical formulations.[2]

Website rekvinalaboratories.com
Face Value ₹ 5
Shares Outstanding 1,11,11,111

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526075.md for Rekvina Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month